CRISPR-Cas9 is a revolutionary tool in part because of its versatility: created by bacteria to chew up viruses, it works equally well in human cells to do all sorts of genetic tricks, including cutting and pasting DNA, making pinpoint mutations and activating or inactivating a gene.
UC Berkeley researchers have now made it even more versatile by giving it an “on” switch, allowing users to keep the Cas9 gene editor turned off in all cells except its designated target.
The redesigned Cas9 enzyme — which the researchers refer to as ProCas9 — is fully functional except for containing a length of protein that needs to be snipped before the enzyme can bind and cut DNA. If scientists insert a short length of protein that can be cut only by a particular enzyme, such as one used exclusively by cancer cells or an infectious virus or bacteria, that enzyme becomes a trigger to turn on Cas9.
ProCas9 essentially “senses” the type of cell it’s in based on the protein-cutting enzyme — a so-called protease — present.
“This is an extra layer of security you could put on the molecule to ensure accurate cutting,” said David Savage, a UC Berkeley associate professor of molecular and cell biology.
It also endows the Cas9 protein with programmable inputs in addition to its programmable outputs.
“There are a lot of proteases that regulate signaling pathways in cells, transform normal cells into cancer cells, and are involved in pathogen infection,” said Savage. “If we can sense these signals, we can tap into and respond accordingly to these important pathways.”
In the study, Savage and his colleagues demonstrated protease control of Cas9 by making it sensitive to both plant and human viruses, such as West Nile Virus. In the future, they believe this sort of technology could be used to import the CRISPR-Cas9 bacterial immune system into plants to help them fend off damaging viral pathogens.
The study by researchers from UC Berkeley and the Gladstone Institutes in San Francisco will be published online Jan. 10 in the journal Cell.
Stripping Cas9 to its essentials
Savage’s original research goal was to pare down the Cas9 protein — the “scissors” that actually snip DNA to do gene editing — to its simplest parts, to get the most robust gene editor possible. The simpler it is, the easier it is to work with and to ferry into cells.
“We know the Cas proteins are complex and that they have all sorts of regulation that is critical to how they function in a bacterial immune system,” he said. “The broad goal of our work is to tame them for use in humans and to strip away the unnecessary things not relevant for genome editing.”
In particular, he wanted to redesign Cas9 so it would be easier to attach other proteins. This would allow Cas9 to carry proteins with a variety of functions to the right spot on DNA. These are known as fusion proteins, promising variants of which can alter gene expression or, in the case of a technology known as base-editing, alter one base or nucleotide in the DNA with pinpoint accuracy.
The technique he used to reengineer Cas9, called circular permutation, has never been tried on a protein as complex as Cas9. Circular permutation involves taking the amino-acid string of the Cas9 protein and cutting it, switching the order of the two segments, and then allowing it to fold into a new 3D configuration. He did this for all possible ways of cutting the protein into two pieces.
While you might think this would completely wreck the protein, in about 10 percent of cases, the new protein still worked, as if he had merely rearranged the protein’s subunits in a different way that did not affect how they functioned. This may work because, as CRISPR-Cas9 inventor Jennifer Doudna and her colleagues have shown, the Cas9 protein complex is highly flexible and moves around as it grabs onto guide RNA, binds to DNA and moves into position to cut DNA strands.
Savage is currently exploring some Cas9 rearrangements that may provide a better scaffold for fusion proteins, bringing them closer to the DNA strand they are targeting.
In the process of rearranging the Cas9 scaffold, he found, serendipitously, that the way in which he reconnected the two protein segments made a difference.
“When we cut the protein and moved the old piece to a new place within the protein, the system became very sensitive to how you linked the two fragments together,” he said. “We realized that we could use that sensitivity to engineer the protein to have protease recognition sites.”
The study shows that “we’re not stuck with what nature gave us with regards to genome-editing proteins,” he said. “These proteins can be elaborately optimized and turned into scaffolds not found in nature but possessing the right properties for use in human cells.”
The Latest on: Gene editing
via Google News
The Latest on: Gene editing
- Gene-editing tool CRISPR repurposed to develop better antibiotics on January 13, 2019 at 11:49 pm
WASHINGTON: Scientists have repurposed the gene-editing tool CRISPR to study which genes are targeted by particular antibiotics, providing clues on how to improve the existing drugs or develop new one... […]
- Gene-editing tool now being used to develop better antibiotics on January 11, 2019 at 8:41 am
A University of Wisconsin–Madison researcher and his collaborators at the University of California, San Francisco have repurposed the gene-editing tool CRISPR to study which genes are targeted by part... […]
- Adding a 'switch' to Cas9 to make CRISPR gene editing safer on January 11, 2019 at 5:56 am
One big challenge facing the development of CRISPR gene editing for use in humans is the fear that the Cas9 "scissors" used in the technology could cause unintended off-target effects. Researchers at ... […]
- Fears of gene editing in the US could be stoked by Russian disinformation attacks on January 10, 2019 at 4:06 am
[There’s a] risk to gene drive research that has flown under the radar. This threat combines legitimate concerns about the safety of gene drives with skepticism about science and information ... […]
- Chinese scientist was told not to create world's first gene-edited babies on January 9, 2019 at 8:22 am
Chinese scientist He Jiankui announced in November that he had created the first gene-edited babies, twin girls whose DNA had been edited using the CRISPR-Cas9 tool to protect them from HIV. Editing t... […]
- CRISPR cadre: Check out the 12 Mass. companies exploring gene editing on January 9, 2019 at 8:21 am
The gene-editing technology CRISPR/Cas9 is causing a ripple effect throughout the life sciences, with several Massachusetts companies exploring or expanding their work with the groundbreaking science. ... […]
- Perspectives on gene editing on January 9, 2019 at 8:00 am
Medicine is at a turning point, on the cusp of major change as disruptive technologies such as gene, RNA, and cell therapies enable scientists to approach diseases in new ways. The swiftness of this c... […]
- He Jiankui Gene Editing Controversy: The Road to Hell is Paved With Good Intentions | Opinion on January 9, 2019 at 2:03 am
It appears that researchers in China have facilitated the birth of the first “designer baby”—actually babies, twin girls who are supposedly genetically resistant to HIV. The scientist who created the ... […]
- Bill Gates Says Gene Editing Will Worsen Inequality Amid Genetically Edited Babies Controversy on January 9, 2019 at 1:40 am
Bill Gates doesn't think we're talking about the effects and issues of gene editing enough. In a December blog post, the Microsoft founder and billionaire opened up about his thoughts on gene editing ... […]
- Researchers overcome hurdle in CRISPR gene editing for muscular dystrophy on January 8, 2019 at 3:42 pm
The gene editing technique known as CRISPR is a revolutionary approach to treating inherited diseases. However, the tool has yet to be used to effectively treat long-term, chronic conditions. A resear... […]
via Bing News